Berobenatide
Sponsors
Pfizer
Conditions
ApneaObesityOverweightOverweight and/or ObesitySleep Disorders
Phase 3
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
Not yet recruitingNCT07792954
Start: 2026-09-01End: 2028-05-23Target: 300Updated: 2026-09-04
A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)
Not yet recruitingNCT07794761
Start: 2026-09-28End: 2029-03-14Target: 180Updated: 2026-09-04
A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)
Not yet recruitingNCT07794774
Start: 2026-09-28End: 2029-02-21Target: 197Updated: 2026-09-04
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
Not yet recruitingNCT07823608
Start: 2026-09-19End: 2028-06-19Target: 258Updated: 2026-09-16